H. de Cremoux

发表

Bronchoalveolar disease in dyskeratosis congenita.

P. Saiag, J. Bignon, F. Verra, 1992, The European respiratory journal.

Lack of a relationship between the polymorphism of debrisoquine oxidation and lung cancer.

J. Dalphin, P. Bechtel, J. Barré, 1991, British journal of clinical pharmacology.

Effects of indomethacin on pulmonary hemodynamics and gas exchange in patients with pulmonary artery hypertension, interference with hydralazine.

C. Brun-Buisson, F. Lemaire, S. Adnot, 1987, The American review of respiratory disease.

High Frequency Chest Wall Oscillation in Patients wih Chronic Air-Flow Obstruction

L. Brochard, A. Harf, D. Isabey, 1987 .

Partial characterisation of an elastase‐like enzyme secreted by human and monkey alveolar macrophages

M. Jaurand, W. Hornebeck, J. Bignon, 1978, The Journal of pathology.

Systemic mastocytosis following mediastinal germ cell tumor: an association confirmed.

P. Gaulard, P. Chariot, I. Monnet, 1993, Human pathology.

Systemic mast cell disease associated with primary mediastinal germ cell tumor.

J. Droz, P. Chariot, I. Monnet, 1991, The American journal of medicine.

Phase I/II study of escalating doses of vinorelbine in combination with oxaliplatin in patients with advanced non-small-cell lung cancer.

P. Soulié, E. Brain, M. Bekradda, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Alternating radiotherapy and chemotherapy schedules in limited small cell lung cancer: analysis of local chest recurrences.

R. Arriagada, T. Chevalier, T. le Chevalier, 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Influence of pretreatment clinical characteristics on the response rate to mitomycin/vindesine/cisplatin (MVP) in unresectable non-small cell lung cancer. ATTIT (Association pour le Traitement des Tumeurs Intra-Thoraciques).

M. Riggi, E. Cvitkovic, L. Vergne, 1991, European journal of cancer.

Histiocytic medullary reticulosis occurring with small cell lung carcinoma.

I. Monnet, H. de Cremoux, C. Chleq, 1991, The European respiratory journal.

Phase II study of oxaliplatin in poor-prognosis non-small cell lung cancer (NSCLC). ATTIT. Association pour le Traitement des Tumeurs Intra Thoraciques.

J. Armand, P. Soulié, E. Cvitkovic, 1998, European journal of cancer.

Extensive oxidative metabolism of dextromethorphan in patients with almitrine neuropathy.

D. Pessayre, L. Bélec, R. Gherardi, 1989, British journal of clinical pharmacology.

Combination of chemotherapy and radiotherapy in limited small cell lung carcinoma: results of alternating schedule in 109 patients.

R. Arriagada, T. le Chevalier, H. de Thé, 1988, NCI monographs : a publication of the National Cancer Institute.

Recurrent chromosome aberrations in human lung squamous cell carcinomas.

B. Dutrillaux, J. Bignon, E. Viégas-Péquignot, 1990, Cancer genetics and cytogenetics.

Cisplatin and continuous infusion vindesine and 5-fluorouracil in non-small cell lung cancer (NSCLC) (ATTIT 002). ATTIT (Association pour le Traitment des Tumeurs Intra-Thoraciques)

M. Riggi, E. Cvitkovic, I. Monnet, 1993, European journal of cancer.

[Pulmonary rehabilitation and non-invasive ventilation before lung surgery in very high-risk patients].

P. Bagan, C. Raynaud, H. de Cremoux, 2013, Revue des maladies respiratoires.

[Bioclinical conference on pneumology. Hôpital Laënnec. Case no 2--4 December 1984. Pulmonary opacity associated with episcleritis and rhizomelic polyarthritis].

P. Duroux, H. de Cremoux, Lange, 1986, Revue de pneumologie clinique.

Cytogenetic study of five cases of lung adenosquamous carcinomas.

B. Dutrillaux, J. Bignon, E. Viégas-Péquignot, 1992, Cancer genetics and cytogenetics.

Competing events determining relapse-free survival in limited small-cell lung carcinoma. The French Cancer Centers' Lung Group.

R. Arriagada, T. le Chevalier, A. Kramar, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Ciliary abnormalities in bronchial epithelium of smokers, ex-smokers, and nonsmokers.

J. Bernaudin, F. Lebargy, E. Escudier, 1995, American journal of respiratory and critical care medicine.

Prospective screening for ALK: clinical features and outcome according to ALK status.

M. Antoine, M. Wislez, T. Chinet, 2014, European journal of cancer.

Alternating radiotherapy and chemotherapy in 173 consecutive patients with limited small cell lung carcinoma. GROP and the French Cancer Center's Lung Group.

R. Arriagada, T. le Chevalier, P. Baldeyrou, 1990, International journal of radiation oncology, biology, physics.

Two cases of non-small-cell lung cancer with rare complex mutation of EGFR exon 18 but different response to targeted therapy.

S. Culine, V. Meignin, P. de Cremoux, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Chest pain and thoraco-abdominal mass.

P. Chariot, I. Monnet, H. de Cremoux, 1991, Chest.

Pulmonary sarcoidosis: evaluation with high-resolution CT.

P Grenier, P. Grenier, M. Brauner, 1989, Radiology.

Features of asbestos-exposed and unexposed mesothelioma.

P. Brochard, J. Bignon, L. Di Menza, 1982, American journal of industrial medicine.

Inherited factors in diffuse bronchiectasis in the adult: a prospective study.

J. Bernaudin, E. Escudier, M. Boucherat, 1991, The European respiratory journal.

Pathological and pathogenetic aspects of chronic obstructive lung disease.

J. Bignon, H. de Cremoux, H. de Crémoux, 1980, Bulletin europeen de physiopathologie respiratoire.

Sialidase activity and antibodies to sialidase-treated autologous erythrocytes in bronchoalveolar lavages from patients with idiopathic pulmonary fibrosis or sarcoidosis.

C. Lambré, J. Bignon, H. de Cremoux, 1988, Clinical and experimental immunology.

Interactions between cigarette smoking and the natural history of idiopathic pulmonary fibrosis.

P Brochard, J. Bernaudin, P. Brochard, 1990, Chest.

Limited small cell lung cancer: possible prognostic impact of initial chemotherapy doses.

R. Arriagada, T. le Chevalier, H. de Thé, 1989, Bulletin du cancer.

Alternating radiotherapy and chemotherapy in limited small cell lung cancer: the IGR protocols. French FNCLCC Lung Cancer Study Group.

R. Arriagada, T. le Chevalier, P. Ruffié, 1994, Lung cancer.

Experience of the Institut Gustave-Roussy in alternating radiotherapy and chemotherapy schedules as induction treatment in limited small-cell lung cancer.

R. Arriagada, T. le Chevalier, H. de Thé, 1988, Antibiotics and chemotherapy.

Bronchoalveolar lavage fluid and serum complement activity in pulmonary sarcoidosis.

C. Lambré, J. Bignon, H. de Cremoux, 1986, The American review of respiratory disease.

[Dental prosthesis technician, a subject with risk of Erasmus syndrome. Apropos of a case].

J. Roujeau, O. Chosidow, J. Revuz, 1991, Annales de dermatologie et de venereologie.

Severe mucositis after chemotherapy with vinorelbine, 5-fluorouracil, leucovorin and cisplatin.

P. Chariot, E. Cvitkovic, I. Monnet, 1991, European journal of cancer.

An open phase II trial of gemcitabine, oxaliplatin and vinorelbine combination as first-line therapy in advanced non-small cell lung cancer patients.

S. Culine, J. Trédaniel, J. Alexandre, 2009, Lung cancer.